Clinical Trials for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Find clinical trials for metabolic dysfunction-associated steatotic liver disease (masld). Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT ID: NCT05395481

This clinical trial is studying a new medication called LY3849891 to see if it is safe and how well it works for people with nonalcoholic fatty liver disease, particularly those who have a specific...

Recruiting

Phase: PHASE1 Type: interventional Locations: Orange, California, United States, Tustin, California, United States +17 more

Fibrosis Lessens After Metabolic Surgery

NCT ID: NCT06374875

This clinical trial, titled "Fibrosis Lessens After Metabolic Surgery," is investigating how metabolic surgery can help people with a liver condition known as Metabolic Dysfunction-associated Steat...

Recruiting

Phase: PHASE4 Type: interventional Locations: Rochester, Minnesota, United States, London, , United Kingdom +20 more

Stimulating Fat Tissue Storage with Niacin to Reduce Fat Accumulation in the Liver.

NCT ID: NCT06843148

This clinical trial is looking at how a vitamin called niacin (also known as vitamin B3) can help reduce fat in the liver for people aged 50 to 80 who have a condition called Metabolic Dysfunction-...

Not yet recruiting

Phase: NA Type: interventional Locations: Sherbrooke, Quebec, Canada

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions